Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Price:
40.37
CNY
-3.67%
Market Closed
Market Cap:
17.1B
CNY
Income Statement
Earnings Waterfall
Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co Ltd
|
Revenue
|
6.1B
CNY
|
|
Cost of Revenue
|
-1.7B
CNY
|
|
Gross Profit
|
4.4B
CNY
|
|
Operating Expenses
|
-3.7B
CNY
|
|
Operating Income
|
618.3m
CNY
|
|
Other Expenses
|
-25.9m
CNY
|
|
Net Income
|
592.4m
CNY
|
Income Statement
Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co Ltd
Currency: CNY
Millions
TTM
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Revenue |
2 637
N/A
|
3 144
+19%
|
3 107
-1%
|
3 808
+23%
|
4 022
+6%
|
4 323
+7%
|
4 660
+8%
|
4 805
+3%
|
5 014
+4%
|
5 069
+1%
|
5 332
+5%
|
5 550
+4%
|
5 522
0%
|
5 756
+4%
|
5 959
+4%
|
6 108
+3%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(650)
|
(772)
|
(812)
|
(986)
|
(987)
|
(1 087)
|
(1 171)
|
(1 205)
|
(1 271)
|
(1 327)
|
(1 411)
|
(1 441)
|
(1 472)
|
(1 607)
|
(1 689)
|
(1 749)
|
|
| Gross Profit |
1 987
N/A
|
2 372
+19%
|
2 295
-3%
|
2 822
+23%
|
3 036
+8%
|
3 237
+7%
|
3 489
+8%
|
3 600
+3%
|
3 743
+4%
|
3 742
0%
|
3 921
+5%
|
4 109
+5%
|
4 051
-1%
|
4 148
+2%
|
4 270
+3%
|
4 360
+2%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(1 341)
|
(1 630)
|
(1 534)
|
(1 961)
|
(2 061)
|
(2 209)
|
(2 399)
|
(2 499)
|
(2 621)
|
(2 632)
|
(2 771)
|
(2 917)
|
(3 243)
|
(3 305)
|
(3 425)
|
(3 742)
|
|
| Selling, General & Administrative |
(1 298)
|
(1 567)
|
(1 465)
|
(1 868)
|
(1 943)
|
(2 107)
|
(2 271)
|
(2 353)
|
(2 396)
|
(2 424)
|
(2 590)
|
(2 712)
|
(3 032)
|
(3 146)
|
(3 237)
|
(3 536)
|
|
| Research & Development |
(58)
|
(83)
|
(79)
|
(103)
|
(102)
|
(121)
|
(151)
|
(171)
|
(238)
|
(258)
|
(282)
|
(310)
|
(279)
|
(298)
|
(304)
|
(317)
|
|
| Depreciation & Amortization |
(20)
|
0
|
0
|
0
|
(43)
|
0
|
0
|
0
|
(58)
|
0
|
0
|
0
|
(80)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
35
|
20
|
9
|
10
|
27
|
19
|
23
|
25
|
71
|
49
|
101
|
105
|
148
|
138
|
116
|
111
|
|
| Operating Income |
646
N/A
|
742
+15%
|
761
+2%
|
861
+13%
|
975
+13%
|
1 028
+5%
|
1 090
+6%
|
1 101
+1%
|
1 122
+2%
|
1 110
-1%
|
1 151
+4%
|
1 192
+4%
|
807
-32%
|
843
+4%
|
845
+0%
|
618
-27%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
4
|
6
|
16
|
20
|
40
|
65
|
75
|
92
|
91
|
106
|
91
|
57
|
70
|
52
|
79
|
98
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
(0)
|
1
|
0
|
0
|
1
|
(0)
|
1
|
1
|
1
|
1
|
3
|
(1)
|
(1)
|
|
| Total Other Income |
(2)
|
(2)
|
(4)
|
(1)
|
2
|
3
|
6
|
4
|
2
|
(5)
|
(5)
|
(6)
|
(9)
|
(9)
|
(11)
|
(12)
|
|
| Pre-Tax Income |
648
N/A
|
746
+15%
|
773
+4%
|
879
+14%
|
1 018
+16%
|
1 096
+8%
|
1 171
+7%
|
1 198
+2%
|
1 214
+1%
|
1 211
0%
|
1 238
+2%
|
1 243
+0%
|
869
-30%
|
890
+2%
|
912
+3%
|
703
-23%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(104)
|
(124)
|
(124)
|
(140)
|
(154)
|
(165)
|
(178)
|
(174)
|
(163)
|
(151)
|
(141)
|
(143)
|
(110)
|
(113)
|
(118)
|
(105)
|
|
| Income from Continuing Operations |
544
|
623
|
649
|
739
|
864
|
930
|
993
|
1 024
|
1 050
|
1 060
|
1 097
|
1 100
|
759
|
777
|
794
|
599
|
|
| Income to Minority Interest |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
1
|
1
|
3
|
9
|
13
|
(2)
|
(1)
|
(4)
|
(6)
|
|
| Net Income (Common) |
544
N/A
|
622
+14%
|
648
+4%
|
738
+14%
|
863
+17%
|
930
+8%
|
993
+7%
|
1 025
+3%
|
1 051
+3%
|
1 064
+1%
|
1 106
+4%
|
1 113
+1%
|
757
-32%
|
775
+2%
|
791
+2%
|
592
-25%
|
|
| EPS (Diluted) |
1.51
N/A
|
1.46
-3%
|
1.82
+25%
|
1.71
-6%
|
2.12
+24%
|
2.19
+3%
|
2.36
+8%
|
2.44
+3%
|
2.48
+2%
|
2.51
+1%
|
2.61
+4%
|
2.63
+1%
|
1.79
-32%
|
1.83
+2%
|
1.87
+2%
|
1.44
-23%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
